Bank of New York Mellon’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bank of New York Mellon’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-75,622	Closed	-$929K	–	4478
2022 Q4	$929K	Buy	75,622 +2,759	+4%	+$65.8K	﹤0.01%	3222
2022 Q3	$2.39M	Buy	72,863 +38,067	+109%	+$1.08M	﹤0.01%	2736
2022 Q2	$655K	Buy	34,796 +2,586	+8%	+$49.5K	﹤0.01%	3431
2022 Q1	$565K	Buy	+32,210	New	+$661K	﹤0.01%	3637

Bank of New York Mellon's CINC Position: Q1 2023 in Review

Bank of New York Mellon sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 75,622 shares — an estimated $929K sold.

Bank of New York Mellon first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $2.39M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Bank of New York Mellon reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bank of New York Mellon sold 75,622 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $929K.
Bank of New York Mellon first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Bank of New York Mellon's CinCor Pharma, Inc. Common Stock position peaked at $2.39M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.